The reports of these new infections are truly disturbing, and serve to further illustrate the continuingl danger posed by NECC’s steroid injections.
New York, NY (PRWEB) December 07, 2012
As fungal meningitis lawsuits against the New England Compounding Center (NECC) continue to move forward, health officials in two states say a new wave of meningitis-related infections is associated with NECC’s recalled epidural steroid injections, Bernstein Liebhard LLP reports. According to The Wall Street Journal, spinal abscesses have been reported in 23 patients who received the steroids in Tennessee, and 37 patients in Michigan. While the infections have not developed into fungal meningitis, that is a possibility if the abscesses are left untreated.*
“The reports of these new infections are truly disturbing, and serve to further illustrate the continuing danger posed by NECC’s steroid injections,” says Bernstein Liebhard LLP, a nationwide law firm that represents people injured by defective drugs and medical devices. The firm is currently offering free fungal meningitis lawsuit evaluations to anyone allegedly affected by this outbreak and the NECC epidural steroid recall.
NECC, a compounding pharmacy based in Framingham, Massachusetts, recalled 17,000 vials of preservative-free methylprednilosone injections after the drugs were tied to a multi-state outbreak of fungal meningitis and other infections. In October, the company voluntarily recalled all of its products and surrendered its license to operate. According to the U.S. Centers for Disease Control (CDC), 541 people have been sickened by NECC steroids. The case count includes 524 cases of fungal meningitis or meningitis-related infections in people who received epidural steroid injections to treat back pain. Seventeen peripheral joint infections were reported in patients who received steroid injections in their hips, knees, shoulders and other joints. The death toll remains at 36.**
Earlier this month, U.S. District Judge Dennis Saylor ruled that meningitis lawsuits pending in Massachusetts federal court would be consolidated and allowed to move forward (Cole v. New England Compounding Pharmacy, 12- 12066, U.S. District Court, District of Massachusetts). In October, plaintiffs in federally-filed fungal meningitis lawsuits petitioned the U.S. Judicial Panel for Multidistrict Litigation (JPML) for establishment of a consolidated litigation in Minnesota federal court. NECC has requested that the litigation be transferred to federal court in Massachusetts.
The JPML is expected to hear arguments on the proposed consolidation in January. [In Re: New England Compounding Pharmacy, Inc. Products Liability Litigation, MDL No. 2419 (JPML).]
Alleged victims of the fungal meningitis outbreak linked to NECC’s epidural steroid injections may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing a fungal meningitis lawsuit by visiting Bernstein Liebhard LLP’s website http://www.consumerinjurylawyers.com/. For additional information, contact one of the firm’s fungal meningitis lawyers today at (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP